The chain of setbacks in previous trials began in 2014 with the drug gantenerumab, followed by crenezumab, solanezumab and aducanumab. The failed attempts, each involving multi-million dollar…
Highly Cited: Several DZNE Scientists Among the World’s Most Influential Researchers
Researchers whose studies are widely quoted in scientific journals are considered influential – because a…
DZNE researchers discover link between the protein medin and Alzheimer's disease.
DZNE researchers discover link between the protein medin and Alzheimer's disease.
Bonn, November, 17th ,…
Laboratory study: Researchers develop basis for new therapies of early childhood epilepsies
Epileptic encephalopathies are specific forms of epilepsy that are often caused by genetic defects.…
Curriculum Vitae
Degrees 2014 Habilitation, University of Bonn 2011 Specialized Pharmacologist (Fachpharmakologin DGPT), German Society of Experimental and…
Breuer-Stiftung awards Best Paper Prize to young DZNE researchers
For the second time, the Hans and Ilse Breuer Foundation has given special awards for outstanding publications to young…
Core KAP (Cooperation Unit for Applied Prevention Research)
Die Core KAP wird geleitet von
When the memory becomes weaker
Do you or your family members notice memory impairment or other mental…
New method for cell investigation
A unique technique enables researchers in Tübingen to follow what happens in brain cells in neurodegenerative diseases ̶ as if they were watching a live…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
